Clinical Trials Logo

Clinical Trial Summary

The persistent political conflicts and COVID-19 pandemic have led to elevated chronic stress levels in Hong Kong, with far-reaching and profound negative impacts on the citizen's mental health. An important pathway via which chronic stress negatively impacts health is through promoting high-risk behaviours, such as addiction, suicide, and antisocial acts. Therefore, testing means to break the association between chronic stress and high-risk behaviour is essential to reducing the adverse consequences of stress and promoting stress resilience. The transcranial direct current stimulation (tDCS) may be a viable method for reducing risky tendency in high-stress individuals, through modulating brain functions and plasticity. Although single-session tDCS has been shown to reliably reduce risky decision making and behaviours acutely, its efficacy over extended periods of time has not been demonstrated, particularly among non-clinical samples. Being able to show that tDCS could lead to long-lasting reduction of risky tendency is necessary for promoting the wide application of this method in therapeutic settings. In this project, we aim to conduct a randomised control trial to systematically and comprehensively test whether 10 sessions of tDCS on either the dorsolateral prefrontal cortex or the orbitofrontal cortex would lead to reduction in risky tendency not only immediately after treatment, but also at 1 month and 3 months after treatment. Participants will be healthy male and female adults (21-40 years old) under relatively high levels of chronic stress, as selected from an online survey prior to the study. Participants will be randomly allocated to one of 3 treatment groups: DLPFC tDCS, OFC tDCS, and sham control. At baseline, participants will complete several risk-taking assessments, including an established computerised task that measures both risk taking and a cognitive bias that was shown to increase irrational risky tendency (illusion of control), an established questionnaire that measures risky decision making in real-life scenarios, and a scale measuring past engagement in common risky activities. Participants will also complete various personality and mood questionnaires, along with assessments on important cognitive abilities. We hypothesized that both DLPFC and OFC tDCS would reduce risk taking across the 3 timepoints, but the effect of DLPFC tDCS would be mediated by reduction in cognitive bias, whereas that of OFC tDCS would be mediated by increase in inhibition functions. These hypotheses will be tested by linear mixed models and mediation analyses. Additional exploratory analyses also test whether the tDCS effect would be moderated by relevant personality factors such as impulsivity.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05501951
Study type Interventional
Source The University of Hong Kong
Contact Li, PhD
Phone 39175655
Email chengli@hku.hk
Status Not yet recruiting
Phase N/A
Start date October 2022
Completion date June 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00747396 - The Bucharest Early Intervention Project N/A
Recruiting NCT05545241 - Awareness of Emotional Feelings and Management of Risky Situations N/A
Completed NCT03268759 - Development of Reward Processing in Prenatally Exposed Adolescents and Young Adults
Completed NCT03762239 - Effect of Air Pollution on the Cognitive Function of Adolescents N/A
Completed NCT05602883 - Music Therapy in the Threat of Premature Birth N/A
Completed NCT04771117 - Defiances to Face COVID-19 Pandemic in Mexico
Completed NCT03159286 - Experimental Test of Facebook Social Drinking Norms on Adolescent Alcohol Use N/A
Completed NCT03087630 - Evaluating Personalized Information and Choices N/A
Completed NCT02707887 - Technology Enhanced Behavioral Activation Treatment for Substance Use N/A
Active, not recruiting NCT04597424 - Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) Phase 3
Completed NCT04311151 - Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior N/A
Not yet recruiting NCT04110756 - ChangeGradients: Promoting Adolescent Health Behavior Change N/A
Completed NCT03036683 - Transcranial Direct Current Stimulation in Offenders N/A
Recruiting NCT05981677 - Social Feedback and Dysfunctional Risk Taking in NSSI Adolescents
Recruiting NCT03370393 - Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects N/A
Completed NCT03962192 - Attitudinal Measures Survey With HISLAC Physicians (SURVEY ONLY) N/A
Completed NCT04145765 - Risk-taking, Self Control and Humor Styles
Completed NCT00186550 - Group Psychotherapy for People With HIV N/A